Adipose stem cells for connective tissue disease with lung scarring
Part of Lungs & breathing, Skin clinical trials.
This trial tests whether stem cells from fat tissue can help people with connective tissue diseases (like lupus or scleroderma) whose lung scarring has worsened despite standard treatments. It aims to slow or stop lung damage.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 20 and 80 years old.
- You have a connective tissue disease like dermatomyositis, scleroderma, lupus, rheumatoid arthritis, or Sjogren's syndrome.
- Your lung scarring has gotten worse even after at least 24 months of steroids and strong immune-suppressing drugs.
- You have a family member or friend who can help support you during the trial.
- Women who can become pregnant must have a negative pregnancy test and use birth control during the trial.
- You do not have severe liver or kidney problems, HIV/AIDS, or other active serious infections.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a combination of two drugs, nintedanib and tocilizumab, can help people with systemic sclerosis (a condition that causes skin and organ hardening) who also have lung scarring (interstitial lung disease). The goal is to find a treatment that can slow down the disease.
This study tests whether a single injection of stem cells from umbilical cord blood can improve lung function in people with interstitial lung disease. It might help reduce inflammation or repair damaged lung tissue.
This study helps doctors identify early signs of lung scarring (fibrosis) in patients with autoimmune diseases like scleroderma, rheumatoid arthritis, and Sjögren's syndrome. By catching this early, researchers hope to better understand and treat these complications.
This trial tests a new treatment using stem cells from umbilical cords to help people with scleroderma-related lung disease. It aims to see if the treatment can slow down or improve lung scarring and breathing problems.
This trial tests giving stem cells from a healthy donor to people with severe scleroderma that affects their lungs or heart. The goal is to see if these donor stem cells can calm the immune system and ease symptoms when standard treatments have stop working.
This study tests whether a person's own fat cells (processed into regenerative cells) can be injected into the hands to improve hand function and reduce skin thickening in systemic sclerosis (scleroderma). It’s designed for people whose hand problems are significant but not too severe.
Hear when a new Connective Tissue Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.